Qube Research & Technologies (QRT)’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.3M | Buy |
2,373,489
+1,432,824
| +152% | +$12.8M | 0.02% | 605 |
|
|
2025
Q1 | $7.05M | Buy |
940,665
+667,821
| +245% | +$5.01M | 0.01% | 1043 |
|
|
2024
Q4 | $2.05M | Buy |
272,844
+18,943
| +7% | +$142K | ﹤0.01% | 1481 |
|
|
2024
Q3 | $1.93M | Buy |
+253,901
| New | +$1.93M | ﹤0.01% | 1431 |
|
|
2024
Q2 | – | Sell |
-667,394
| Closed | -$3.39M | – | 3410 |
|
|
2024
Q1 | $3.39M | Sell |
667,394
-361,109
| -35% | -$1.83M | 0.01% | 1240 |
|
|
2023
Q4 | $6.16M | Buy |
+1,028,503
| New | +$6.16M | 0.01% | 779 |
|
|
2023
Q3 | – | Sell |
-214,095
| Closed | -$1.51M | – | 3655 |
|
|
2023
Q2 | $1.51M | Buy |
+214,095
| New | +$1.51M | 0.01% | 1084 |
|
|
2021
Q3 | – | Sell |
-40,503
| Closed | -$640K | – | 2208 |
|
|
2021
Q2 | $640K | Sell |
40,503
-5,749
| -12% | -$90.8K | 0.01% | 1145 |
|
|
2021
Q1 | $470K | Buy |
+46,252
| New | +$470K | 0.01% | 1215 |
|
|
2020
Q3 | – | Sell |
-220,891
| Closed | -$1.05M | – | 1681 |
|
|
2020
Q2 | $1.05M | Buy |
+220,891
| New | +$1.05M | 0.02% | 845 |
|
|
2020
Q1 | – | Sell |
-14,836
| Closed | -$51K | – | 1139 |
|
|
2019
Q4 | $51K | Buy |
+14,836
| New | +$51K | ﹤0.01% | 1480 |
|